SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001609351-19-000010
Filing Date
2019-01-17
Accepted
2019-01-17 21:39:05
Documents
1
Period of Report
2019-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154777912840997.html 4  
1 FORM 4 wf-form4_154777912840997.xml 4 6340
  Complete submission text file 0001609351-19-000010.txt   7751
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
High Katherine A (Reporting) CIK: 0001631248 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36819 | Film No.: 19532058